Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目观察血液透析滤过(HDF)及血液透析(HD)对尿毒症脑病疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析患者心血管稳定性影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目：血液透析和尿毒症对肿瘤志物水平影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12人造血管内瘘行血液透析患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目 提高对长期血液透析患者获得性肾囊肿及肾细胞癌发病和临床特点认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目探讨影响出血热病人急性肾衰少尿期预后因素及血液透析在出血热病人中应时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目观察肾康注射液治疗慢性肾功能衰竭疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液透析提供一个好方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目观察透析滤过(HDF)及透析(HD)对尿毒症脑病疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察透析滤过(HDF)对老年透析患者心管稳定响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目：了解透析和尿毒症对肿瘤志物水平响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造管内瘘透析患者,针对其内瘘情况进护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目 提高对长期透析患者获得肾囊肿及肾细胞癌发病和临床特点认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目探讨响出热病人急肾衰少尿期预后因素及透析在出热病人中应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目观察肾康注射治疗慢肾功能衰竭疗效,为控制慢肾衰患者肾衰进程而延缓进透析提供一个好方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目观察血液透析滤过(HDF)及血液透析(HD)对症脑病疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析患者心血管稳定性。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目：了解血液透析症对肿瘤志物水平。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血液透析患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目 提高对长期血液透析患者获得性肾囊肿及肾细胞癌发病临床特点认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目探讨出血热病人急性肾衰少期预后因素及血液透析在出血热病人中应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目观察肾康注射液治疗慢性肾功能衰竭疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液透析提供一个好方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液透(HDF)及血液透(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透和腹膜透两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透(HDF)对老年透患者心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液透和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘血液透的患者,针对其内瘘情况理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血液透患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液透在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰程而延缓血液透提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

观察血液透析滤过(HDF)及血液透析(HD)对尿毒症脑病疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析患者心血管稳定性影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 ：解血液透析和尿毒症对肿瘤志物水平影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例造血管内瘘行血液透析患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

提高对长期血液透析患者获得性肾囊肿及肾细胞癌发病和临床特点认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

探讨影响出血热病急性肾衰少尿期预后因素及血液透析在出血热病中应时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

观察肾康注射液治疗慢性肾功能衰竭疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液透析提供一个好方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察析滤过(HDF)及析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有析和腹膜析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察析滤过(HDF)对老年析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解析和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造管内瘘行析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,虑析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及析在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行析提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液滤过(HDF)及血液(HD)尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液和腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液滤过(HDF)老年者心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液和尿毒症肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管瘘行血液的者,针瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高长期血液者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰者肾衰进程而延缓进行血液提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液滤过(HDF)及血液(HD)尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液和腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液滤过(HDF)老年患者心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液和尿毒症肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血液的患者,针其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容,以考虑血液治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高长期血液患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液在出血热病人中的应用机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液透析滤过(HDF)及血液透析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液透析和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血液透析的,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血液透析得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液透析在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰肾衰进程而延缓进行血液透析提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观透析滤过(HDF)及透析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观透析滤过(HDF)对老年透析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解透析和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观12例使用人造管内瘘行透析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期透析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及透析在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观肾康注射治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行透析提供一个好的方法。